Singapore markets close in 6 hours 51 minutes
Straits Times Index
3,326.35 +0.07 (+0.00%) Nikkei
39,666.46 +493.31 (+1.26%) Hang Seng
18,039.50 -33.40 (-0.18%) FTSE 100
8,247.79 -33.76 (-0.41%) Bitcoin USD
62,080.83 +1,513.95 (+2.50%) CMC Crypto 200
1,286.44 +37.31 (+2.99%)
SANA Oct 2024 12.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:14PM EDT. Market open.
| Previous close | 4.8100 |
| Open | 4.8300 |
| Bid | 4.9000 |
| Ask | 5.4000 |
| Strike | 12.50 |
| Expiry date | 2024-10-18 |
| Day's range | 4.8100 - 4.9000 |
| Contract range | N/A |
| Volume | |
| Open interest | 500 |
GlobeNewswireSana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data Showing the Potential for Pluripotent Stem Cell-Derived Human Glial Progenitor Cell Transplantation as a Treatment for Huntington’s Disease and Other Glial-based Neurodegenerative Conditions
Healthy transplanted human glial cells replaced diseased glial cells in the brains of human glial chimeric Huntingtin mice Additional proof-of-concept for the advancement of SC379, Sana’s pluripotent stem cell-derived glial progenitor cell product candidate SEATTLE, May 21, 2024 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today highlighted that Nature Biotechnology has published a paper titled “You
Simply Wall St.Is Sana Biotechnology (NASDAQ:SANA) In A Good Position To Invest In Growth?
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...
- GuruFocus.com
Sana Biotechnology Inc (SANA) Reports First Quarter 2024 Financial Results
Aligns with Analyst Projections Amidst Strategic Clinical Advancements
© 2024 Yahoo. All rights reserved.